At-home full-body stimulation suit to manage spasticity and ataxia in MS
Official title: Home-Based Neuromodulation Suits for Reducing Spasticity and Ataxia in Multiple Sclerosis: A Multi-center RCT
Run by Universitair Ziekenhuis Brussel · NCT07202195 · Data updated 2026-11-12
This project will try whether wearing a full-body electrical stimulation suit for six weeks helps people with MS who have spasticity or ataxia reduce symptoms and improve daily functioning.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Universitair Ziekenhuis Brussel Academic / other |
| Locations | 2 sites (Steenokkerzeel and 1 other locations) |
| Status | Recruiting |
| Started | March 16, 2026 |
| Main results expected | September 2027 |
| Study ends | September 2027 |
| Registry record updated | October 8, 2026 |
| Trial ID | NCT07202195 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with a confirmed diagnosis of multiple sclerosis who have spasticity (MAS ≥ 1) or ataxia (SARA ≥ 4) and who can understand instructions and complete questionnaires are the intended participants.
✕Probably not a fit
People with implanted electronic devices, recent relapse or recent changes in disease-modifying treatment, recent Botulinum toxin A, acute musculoskeletal problems, or insufficient cognitive ability are unlikely to be eligible or to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study compares two groups of people with MS: an intervention group who will wear a full-body electrostimulation suit and a control group who will receive usual care. Intervention participants wear the suit during a one-week admission at the MS center and then at home for five additional weeks, using it daily or every other day. Clinical tests are performed at the MS center after 1 week and after 6 weeks to measure spasticity, ataxia, and functional changes. Usual care continues for both groups throughout the study.
Why it matters
Potential benefit: If successful, the suit could reduce muscle stiffness and improve coordination and everyday mobility for people with MS.
How similar studies have gone: Small studies of targeted electrical neuromodulation have shown mixed benefits for MS symptoms, but full-body stimulation suits are a relatively novel approach with limited published evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Eligible participants must have ataxia or spasticity alongside impairments in upper or lower extremity physical function. MAS score ≥ 1 will be used as an inclusion criterion to determine the presence of spasticity. SARA score ≥ 4 will be used as an inclusion criterion to determine the presence of ataxia. Note: one of the two criteria (MAS score or SARA score) must be fulfilled for a pwMS to be eligible. * The patient must have the cognitive abilities to understand instructions and to be able to complete the questionnaires adequately * Diagnosis of multiple sclerosis. Exclusion Criteria: * Implanted devices (like pacemaker, Baclofen pump, neurostimulator, defibrillator, shunts, ECG equipment, electronic life support, high frequency operation equipment ) * Change in disease modifying treatment within the last 3 months * Use of Botuline Toxine A within the last 3months * Recent relapse within the last 3 months * Acute musculoskeletal problems that hinder the test performance, * Pregnancy * Sizes bigger than 3XL (triple eXtra Large) * Skin eruptions and/or skin areas in the stimulation zone that are swollen, infected or inflamed.
Where it's running
-
Nationaal MS Center Melsbroek
Steenokkerzeel, Belgium Recruiting -
The Danish MS Hospitals
Ry, Denmark Recruiting
Study contacts
- Principal investigator: Daphne Kos — Universitair Ziekenhuis Brussel
- Study coordinator: Daphne Kos
- Email: daphne.kos@uzbrussel.be
- Phone: +32496107849
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using short selfie videos to measure walking and speech changes in people with MS
This project will test whether short selfie videos taken by people with MS can reliably show walking and speech changes similar to what clinicians see in person.
-
Cryoneurolysis for shoulder pain and spasticity management
This study tests if a new cold treatment for shoulder pain can help people with hemiplegia feel better and move better compared to the usual botulinum injections.
-
Using dry needling to treat muscle tightness in people with Multiple Sclerosis
This study is testing if dry needling can help people with Multiple Sclerosis reduce muscle tightness and improve their balance and walking.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.